Assenagon Asset Management S.A. / BSX
Assenagon Asset Management S.A.’s Boston Scientific Corp Position
Does Assenagon Asset Management S.A. own Boston Scientific Corp (BSX)? Yes — 4.17M shares worth $178M (+0.22% of its 13F portfolio) as of Q2 2026, down from 10.06M shares the prior filed quarter.
Position Value
$178M
Q2 2026
Shares
4.17M
% of Portfolio
+0.22%
Quarters Held
30
currently held
Position History BSX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 4.17M | $178M | +0.22% |
| Q1 2026 | 10.06M | $631M | +0.96% |
| Q4 2025 | 4.31M | $411M | +0.57% |
| Q3 2025 | 2.91M | $285M | +0.39% |
| Q2 2025 | 2.67M | $287M | +0.43% |
| Q1 2025 | 2.49M | $251M | +0.42% |
| Q4 2024 | 949.0K | $85M | +0.14% |
| Q3 2024 | 3.90M | $327M | +0.60% |
| Q2 2024 | 2.95M | $227M | +0.50% |
| Q1 2024 | 3.09M | $212M | +0.50% |
| Q4 2023 | 2.06M | $119M | +0.32% |
| Q3 2023 | 3.26M | $172M | +0.53% |
| Q2 2023 | 3.12M | $168M | +0.58% |
| Q1 2023 | 1.93M | $97M | +0.34% |
| Q4 2022 | 2.47M | $114,136 | +0.41% |
| Q3 2022 | 3.76M | $146M | +0.56% |
| Q2 2022 | 3.12M | $116M | +0.43% |
| Q1 2022 | 3.08M | $136M | +0.38% |
| Q4 2021 | 2.02M | $86M | +0.25% |
| Q3 2021 | 4.24M | $184M | +0.59% |
| Q2 2021 | 3.50M | $149M | +0.51% |
| Q1 2021 | 3.39M | $131M | +0.53% |
| Q4 2020 | 5.29M | $190M | +0.83% |
| Q3 2020 | 834.0K | $32M | +0.18% |
| Q1 2020 | 583.7K | $19M | +0.15% |
| Q4 2019 | 1.46M | $66M | +0.41% |
| Q3 2019 | 77.2K | $3M | +0.02% |
| Q2 2019 | 339.3K | $15M | +0.11% |
| Q1 2019 | 692.0K | $27M | +0.25% |
| Q4 2018 | 74.8K | $3M | +0.03% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Assenagon Asset Management S.A.’s full portfolio or all institutional holders of BSX.